Chimeric Peptidomimetic Antibiotic Efficiently Neutralizes Lipopolysaccharides (LPS) and Bacteria-Induced Activation of RAW Macrophages-Reference-Cited by-同舟云学术

Chimeric Peptidomimetic Antibiotic Efficiently Neutralizes Lipopolysaccharides (LPS) and Bacteria-Induced Activation of RAW Macrophages

Published:2023-02-15 Issue:3 Volume:9 Page:518-526
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Javed Ali¹²,Slingerland Cornelis J.³^ORCID,Wood Thomas M.³,Martin Nathaniel I.³^ORCID,Broere Femke¹,Weingarth Markus H.²^ORCID,Veldhuizen Edwin J. A.¹^ORCID

Affiliation:

1. Faculty of Veterinary Medicine, Department of Biomolecular Health Sciences, Division Infectious Diseases & Immunology, Section Immunology, Utrecht University, 3584 CL Utrecht, The Netherlands

2. NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, 3584 CS Utrecht, The Netherlands

3. Biological Chemistry Group, Institute of Biology Leiden, Leiden University, 2333 BE Leiden, The Netherlands

Funder

H2020 European Research Council

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00518

Reference40 articles.

1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

2. The global preclinical antibacterial pipeline